About Us

RDx Bioscience supports risk-bearing entities by applying laboratory tools and programs to achieve their quality goals.

RDx BioScience, an advanced CAP accredited and CLIA certified clinical diagnostic laboratory prides itself in providing comprehensive diagnostic testing. We operate on a principle-of-service designed around the needs of your practice, personalized to your preferences, and always exceeding industry standards. RDx BioScience is strongly committed to continual innovation in testing services. Meaning, we always strive to provide access to the latest specialized clinical tests for our patients and healthcare providers. With the skyrocketing prevalence of health problems, the landscape of healthcare delivery is evolving with a sharp focus on preventing costly chronic conditions. Clinicians must find ways to administer effective quality care while empowering patients to lead healthier lives. We believe that our comprehensive service model is the most effective way to confront chronic disease in the everchanging healthcare world.
N
RDx BioScience endorses the shift by healthcare providers to accept risk-based contracts with emphasis on creating value through quality and clinical outcomes.
N
With expertise in risk-based contracting and new diagnostic tools, RDx BioScience supports health organizations through detailed guidance to gain additional competitive advantage.
N
RDx BioScience has proprietary algorithms to support delegated medical groups, ACOs, Medicare STARs, MIPS and state-based Medicaid incentive bonuses to deliver remarkable results.
N
RDx Bioscience is dedicated to providing support to risk-bearing entities additional laboratory tools and programs to achieve their quality goals.

Cost Containment

RDx Bioscience created several programs for risk-bearing entities to reduce re-admissions, future utilization and improved care coordination based on proprietary medication adherence assays, genetic testing and other laboratory interventions.

Risk Adjustment

RDx Bioscience has specialty algorithms for the identification of additional chronic illnesses through laboratory analysis.

Quality Measures

RDx Bioscience supports organizations in closing quality gaps in care and monitoring outcome measures in Medicare STARs, ACOs and State Medicaid programs.

RDx BioScience embraces and supports ASAM guidelines for appropriate testing:

N

Clinical leadership of addictionology physicians with decades of expertise

N

Ongoing validation for testing of newly designed synthetic drugs

N

Guidance on best practices for diagnostics in addiction treatment

N

Very low testing cutoff levels

N

Rapid turnaround times necessary for appropriate treatment

N

Consultations with PhD toxicologists for rapid interpretation of results

N

A full blood and genetics test menu, to evaluate the complete health of the client who seeks sobriety

N

Oral testing capabilities